In an age where patients have more choice about treatment options (just think about how the treatment guidelines have evolved for multiple sclerosis or rheumatoid arthritis in the last 10 years for example,) and more clinical trials are being conducted by fewer investigators, there has been a constant upward pressure on competition for clinical trial patients, even as sponsors and third party recruitment companies becomes more innovative and proactive in their approaches to marketing their trials.
We are very excited to be attending next week’s 12th Annual Meeting DIA Japan 2015, to be held at Tokyo Big Sight in Tokyo, November 15 – 17. It’s the first time that many of us based here in our U.S. headquarters will be joining our Japan team since opening our new Tokyo office over the summer. Under the theme “Medicine Development” this year’s event is set to focus on the innovative and constructive influence of patients on the enterprise of clinical R&D – a topic that’s always at the center of our work here at BBK.
Just about everyone carries a mobile device these days. Whether you’re in line for your morning coffee or on the treadmill at the gym, most people have their phones close at hand. So how can we utilize today’s connected mHealth model to better tap into clinical trial patients through means they are already using, such as their phones?
Early last week Apple excited many and rattled others with its ResearchKit announcement. The open-source toolkit or “framework” includes disease-specific applications that patients can use to track their symptoms, and will allow researchers to gather data from iPhone users to help further medical research. While reaction has been mixed, most agree that tools that help medical science advance and make people and patients more involved are welcome innovations. But clinical research and medical research aren’t the same. Running a global clinical trial is much different than creating and delivering apps to aid research on a particular disease.
Show of hands who plays Fantasy (American) Football please… I know I do. And so do 19 of my colleagues here at BBK. (That’s 23.75% of our workforce). We form two separate leagues, each consisting of ten teams apiece, where we battle for FF (Fantasy Football) supremacy.
Topics: Site Selection
Prevention vs. Treatment
Google’s semi-secret and futuristic research lab, Google X, is busy working on something new – the Baseline Study. The idea is to define what it means to be “healthy” so that one day, this health baseline might help us better detect certain health risks and identify changes relating to serious, more debilitating diseases before they worsen.
Towards the end of the third age of our earth, great Internet browsers of power were forged by the tech smiths of Silicon Valley.
I tell my team that anything is possible within programming. Well. Maybe not anything. I mean – a computer can’t win the Olympic 100-meter dash for one! But when it comes to the programming world – there are always multiple ways of molding any innovative idea (new business requirements) into a working model (product).
Moneyball. It’s a gift that keeps on giving for me as a guy wrapped up in patient recruitment data. As an ex-patriot Brit, I must admit that it took me about 10 years to start to appreciate baseball, and it has taken another 10 to figure out just some of the intricacies. A seemingly simple game, it is filled with deeply meaningful and detailed subtexts, and perhaps it is not without irony then that the game lends itself so well to so many “sports-as-life” American metaphors.